Last reviewed · How we verify
Closed loop with sensor and Insulin — Competitive Intelligence Brief
phase 2
Insulin delivery system / Artificial pancreas
Diabetes
Small molecule
Live · refreshed every 30 min
Target snapshot
Closed loop with sensor and Insulin (Closed loop with sensor and Insulin) — Albert Einstein College of Medicine. A closed-loop insulin delivery system that uses continuous glucose monitoring to automatically adjust insulin infusion in real-time, mimicking the body's natural glucose regulation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Closed loop with sensor and Insulin TARGET | Closed loop with sensor and Insulin | Albert Einstein College of Medicine | phase 2 | Insulin delivery system / Artificial pancreas |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Insulin delivery system / Artificial pancreas class)
- Albert Einstein College of Medicine · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Closed loop with sensor and Insulin CI watch — RSS
- Closed loop with sensor and Insulin CI watch — Atom
- Closed loop with sensor and Insulin CI watch — JSON
- Closed loop with sensor and Insulin alone — RSS
- Whole Insulin delivery system / Artificial pancreas class — RSS
Cite this brief
Drug Landscape (2026). Closed loop with sensor and Insulin — Competitive Intelligence Brief. https://druglandscape.com/ci/closed-loop-with-sensor-and-insulin. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab